AbbVie Inc. (ABBV) vs BRISTOL MYERS SQUIBB CO (BMY)
Side-by-side comparison from SEC filings: latest annual financials, insider activity and institutional ownership.
| Metric | ABBV | BMY |
|---|---|---|
| Sector | Health Care | Health Care |
| Latest fiscal year | FY2025 | FY2025 |
| Revenue | $61.16B | $48.19B |
| Revenue growth (YoY) | ▲ 8.6% | ▼ 0.2% |
| Net income | $4.23B | $7.05B |
| Gross margin | 70.2% | 71.1% |
| Diluted EPS | $2.36 | $3.46 |
| Insider net (6 mo) | +12.3K sh • 1 sells • 0 buys | +46.8K sh • 2 sells • 0 buys |
| Institutional owners | 46 | 47 |
| Institutional value held | $222.87B | $63.76B |
| Next earnings (est.) | Around Feb 3, 2027 | Oct 29, 2026 |
Figures from each company's SEC filings (latest reported fiscal year; fiscal calendars may differ). Next-earnings dates are estimates from historical filing patterns.
About AbbVie Inc. (ABBV)
AbbVie Inc., incorporated in Delaware in 2012, is a global, diversified research-based biopharmaceutical company that became an independent, publicly-traded entity on January 1, 2013, following its spin-off from Abbott Laboratories. Read more →
About BRISTOL MYERS SQUIBB CO (BMY)
Bristol-Myers Squibb Company, incorporated in Delaware in 1933 as successor to a New York business dating to 1887 and renamed following a 1989 merger, is a biopharmaceutical company operating in a single segment focused on discovering, developing… Read more →
Source: SEC EDGAR.